The FASTR brand, founded in 2013 (United States), from 16 sister brands and 2214 competing brands. FASTR is owned by Regeneron Pharmaceuticals, listed on the stock exchange of New York FASTR belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(FASTR)
over 5 years*
USD 2,380.45